Home
About Us
About Us
Board of Directors
Scientific Advisory Board
Management Team
Careers
For Researchers
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
For Partners
Our Current Partners
What We Are Looking For
For Patients
Accessing Kazia Drug Candidates in Clinical Trials
Accessing Kazia Drug Candidates for Compassionate Use
Resources for Patients
For Investors
Press Releases
ASX Announcements
Delisting from ASX
How to convert unlisted shares to ADSs
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Corporate Governance
Shareholder Services
Media Centre
Overview
Video
Coverage
Contact
Contact Us
Subscribe to email alerts
Heading &
Sub-heading can be edited through HQI
Home
>
Media Centre
>
Coverage
Overview
Video
Coverage
Coverage
5-Dec-2022
Kazia Therapeutics talks positive pre-clinical data for EVT801
1-Dec-2022
Almost all sectors higher: Aus shares close up 1%
1-Dec-2022
ASX opens to 7-month high after Powells positive news: Aus shares up 0.8%
30-Nov-2022
Kazia Therapeutics welcomes publication of positive pre-clinical data for EVT801 in peer-reviewed cancer research journal
1-Nov-2022
ASX increases slightly ahead of today's interest rate rise: Aus shares 0.3% higher at noon
28-Oct-2022
US tech earnings weighing down Aus tech sector: ASX falls 0.62% at noon
28-Oct-2022
Stocks of the Hour: Kazia Therapeutics, Green Technology Metals, Winsome Resources
28-Oct-2022
Kazia Therapeutics’ (ASX:KZA) paxalisib shows positive signals against preclinical melanoma models
5-Oct-2022
Kazia Therapeutics takes Phase 2 study of paxalisib international; opens two sites in Australia
27-Sep-2022
Stockhead Health and Biotech Investment Guide
Previous
1
2
3
4
5
6
7
8
Next
